Related Experiment Video
Updated: Nov 3, 2025

08:49
A 3D Organotypic Melanoma Spheroid Skin Model
Published on: May 18, 2018
16.2K
Current Challenges in Access to Melanoma Care: A Multidisciplinary Perspective
Nikhil I Khushalani1, Thach-Giao Truong2, John F Thompson3,4
1Department of Cutaneous Oncology, H. Lee Moffitt Cancer Center, Tampa, FL.
Summary
Melanoma treatment advances offer hope, but access to specialized care remains a global challenge. Improving patient outcomes requires addressing these barriers and implementing supportive policies.
Area of Science:
- Oncology
- Dermatology
- Cancer Care
Background:
- Melanoma diagnosis and treatment necessitate multidisciplinary specialized care.
- Significant advancements have been made in treating both local and advanced melanoma.
- Barriers persist for patients lacking access to specialized melanoma centers.
Purpose of the Study:
- To review recent therapeutic advances in melanoma treatment.
- To identify persistent global challenges in delivering optimal melanoma care.
- To explore tools and policies for improving patient outcomes.
Main Methods:
- Literature review of recent melanoma treatment advances.
- Analysis of challenges in accessing specialized melanoma care.
- Discussion of potential solutions and policy implications.
Main Results:
- Despite therapeutic progress, disparities in care access are evident worldwide.
- Evolving treatment landscape includes complex new drug therapies.
- Challenges in community-based care delivery hinder optimal outcomes.
Conclusions:
- Access to specialized melanoma expertise is crucial for all patients.
- Addressing access barriers is essential for equitable and effective melanoma treatment.
- Policy and strategic interventions are needed to improve global melanoma care standards.
Related Concept Videos
Skin Cancer
5.0K
Skin cancer is a type of cancer that occurs when there is an abnormal growth of skin cells, usually triggered by damage to the DNA within the skin cells. It is primarily caused by exposure to ultraviolet (UV) radiation from the sun or artificial sources like tanning beds. Skin cancer is the most common type of cancer worldwide, and its incidence continues to rise.
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
5.0K
Changes in Skin Color: Clinical Perspectives
2.8K
The first thing a clinician sees is the skin, so the examination of the skin should be part of any thorough physical examination. Most skin disorders are relatively benign, but a few, including melanomas, can be fatal if untreated. A couple of the more noticeable disorders, albinism and vitiligo, affect the appearance of the skin and its accessory organs.
Albinism
Albinism is a genetic disorder that affects (completely or partially) the coloring of skin, hair, and eyes. The defect is primarily...
Albinism
Albinism is a genetic disorder that affects (completely or partially) the coloring of skin, hair, and eyes. The defect is primarily...
2.8K
Tumor Immunotherapy
797
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
797
Treatment Resistant Cancers
3.5K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.5K
Cancer Survival Analysis
491
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
491
Combination Therapies and Personalized Medicine
5.4K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.4K

